Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2019 Jul 1.

Published in final edited form as: Am J Ophthalmol. 2018 Jan 12;191:xli–lviii. doi: 10.1016/j.ajo.2017.12.019

Distribution of the number of injections given in the PRN arms of CATT during the first year of the study for patients treated with (A) ranibizumab or (B) bevacizumab. One in seven (14%) of patients in both groups needed only three or fewer injections to resolve all fluid during the first year of treatment as determined by the treating ophthalmologist.

Distribution of the number of injections given in the PRN arms of CATT during the first year of the study for patients treated with (A) ranibizumab or (B) bevacizumab. One in seven (14%) of patients in both groups needed only three or fewer injections to resolve all fluid during the first year of treatment as determined by the treating ophthalmologist.